{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:54:22Z","timestamp":1778680462555,"version":"3.51.4"},"reference-count":28,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T00:00:00Z","timestamp":1331251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Basic Clin Pharma Tox"],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ursodeoxycholic acid (<jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content>) is the only approved treatment for primary biliary cirrhosis, and norursodeoxycholic acid (<jats:italic>nor<\/jats:italic><jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content>) is currently tested in clinical trials for future treatment of primary sclerosing cholangitis because of beneficial effects in cholestatic<jats:italic>Mdr2<\/jats:italic>knock\u2010out mice. Uptake of<jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content>and<jats:italic>nor<\/jats:italic><jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content>into hepatocytes is believed to be a prerequisite for subsequent metabolism and therapeutic action. However, the molecular determinants of hepatocellular uptake of<jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content>and<jats:italic>nor<\/jats:italic><jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content>are poorly understood. We therefore investigated whether<jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content>and<jats:italic>nor<\/jats:italic><jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content>are substrates of the hepatic uptake transporters<jats:styled-content style=\"fixed-case\">OATP1B1<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\">OATP1B3<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\">OATP2B1<\/jats:styled-content>and Na<jats:sup>+<\/jats:sup>\u2010taurocholate co\u2010transporting polypeptide (<jats:styled-content style=\"fixed-case\">NTCP<\/jats:styled-content>), which are localized in the basolateral membrane of hepatocytes. Uptake of [<jats:sup>3<\/jats:sup>H]<jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content>and [<jats:sup>14<\/jats:sup>C]<jats:italic>nor<\/jats:italic><jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content>into Human embryonic kidney (<jats:styled-content style=\"fixed-case\">HEK<\/jats:styled-content>) cells stably expressing<jats:styled-content style=\"fixed-case\">OATP1B1<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\">OATP1B3<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\">OATP2B1<\/jats:styled-content>or<jats:styled-content style=\"fixed-case\">NTCP<\/jats:styled-content>was investigated and compared with uptake into vector control cells. Uptake ratios were calculated by dividing uptake into transporter\u2010transfected cells by uptake into respective control cells. Uptake ratios of<jats:styled-content style=\"fixed-case\">OATP1B1<\/jats:styled-content>\u2010,<jats:styled-content style=\"fixed-case\">OATP1B3<\/jats:styled-content>\u2010 and<jats:styled-content style=\"fixed-case\">OATP2B1<\/jats:styled-content>\u2010mediated<jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content>and<jats:italic>nor<\/jats:italic><jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content>uptake were at maximum 1.23 and 1.49, respectively. Uptake of<jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content>was significantly higher into<jats:styled-content style=\"fixed-case\">HEK<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">NTCP<\/jats:styled-content>cells only at the lowest tested concentration (1\u00a0\u03bcM,<jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.001) compared with the control cells with an uptake ratio of 1.34\u2010fold.<jats:italic>Nor<\/jats:italic><jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content>was not significantly transported by<jats:styled-content style=\"fixed-case\">NTCP<\/jats:styled-content>. The low uptake rates suggest that<jats:styled-content style=\"fixed-case\">OATP1B1<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\">OATP1B3<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\">OATP2B1<\/jats:styled-content>and<jats:styled-content style=\"fixed-case\">NTCP<\/jats:styled-content>are not relevant for hepatocellular uptake and effects of<jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content>and<jats:italic>nor<\/jats:italic><jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content>in human beings.<\/jats:p>","DOI":"10.1111\/j.1742-7843.2012.00865.x","type":"journal-article","created":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T15:30:34Z","timestamp":1329233434000},"page":"81-86","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Characterization of Ursodeoxycholic and Norursodeoxycholic Acid as Substrates of the Hepatic Uptake Transporters<scp>OATP<\/scp>1B1,<scp>OATP<\/scp>1B3,<scp>OATP<\/scp>2B1 and<scp>NTCP<\/scp>"],"prefix":"10.1111","volume":"111","author":[{"given":"J\u00f6rg","family":"K\u00f6nig","sequence":"first","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology and Toxicology Friedrich\u2010Alexander\u2010Universit\u00e4t Erlangen\u2010N\u00fcrnberg Erlangen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Klatt","sequence":"additional","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology and Toxicology Friedrich\u2010Alexander\u2010Universit\u00e4t Erlangen\u2010N\u00fcrnberg Erlangen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Dilger","sequence":"additional","affiliation":[{"name":"Dr. Falk Pharma GmbH Leinenweberstra\u00dfe 5 Freiburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin F.","family":"Fromm","sequence":"additional","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology and Toxicology Friedrich\u2010Alexander\u2010Universit\u00e4t Erlangen\u2010N\u00fcrnberg Erlangen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,3,9]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep0521"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct074694"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23294"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.09.004"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.10.018"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23911"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.3109\/03602530903491683"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.109.002014"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.110.002857"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.236"},{"key":"e_1_2_7_12_1","first-page":"1","volume-title":"Handbook of Experimental Pharmacology","author":"K\u00f6nig J","year":"2011"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.073908"},{"key":"e_1_2_7_14_1","first-page":"205","volume-title":"Handbook of Experimental Pharmacology","author":"Stieger B","year":"2011"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp050063u"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v113.pm9322525"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.110.034991"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.014407"},{"key":"e_1_2_7_19_1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0026-895X(24)23190-4","article-title":"Drug resistance and ATP\u2010dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells","volume":"55","author":"Cui Y","year":"1999","journal-title":"Mol Pharmacol"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.60.5.934"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M001448200"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.21176"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-003-1130-z"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23810"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20943"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M500532-JLR200"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00364.2005"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1070-z"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32832bcf7b"}],"container-title":["Basic &amp; Clinical Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-7843.2012.00865.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1742-7843.2012.00865.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T19:44:25Z","timestamp":1742499865000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-7843.2012.00865.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,9]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.1111\/j.1742-7843.2012.00865.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1742-7843.2012.00865.x","archive":["Portico"],"relation":{},"ISSN":["1742-7835","1742-7843"],"issn-type":[{"value":"1742-7835","type":"print"},{"value":"1742-7843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,9]]},"assertion":[{"value":"2011-11-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-01-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-03-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}